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Abstract
Background: Candida spp. are members of a genus, including closely related fungal species that cause a variety of infections.
Objectives: The aim of this study was the isolation of various Candida species from vulvovaginitis and urethra of patients in
Neyshabur, Northeast Iran from 2013 to 2015.
Methods: This descriptive-analytical and cross-sectional study was performed to identify Candida spp. causing vulvovaginitis and
Urinary Tract Infection (UTI) at a referral laboratory in Neyshabur district, Khorasan Razavi Province. A total of 451 vaginal and mid-
stream urine samples were collected. Ten micro-liters of each specimen was cultured on CHROM agar plates and then incubated
at 37°C for 24 to 48 hours, aerobically. Candida species were identified based on colony morphology, germ tube production and
micro-morphology on corn meal agar including 1% Tween 80.
Results: The mean age of the patients was 34.7± 16.3. Candida albicans was the predominant species isolated. Moreover, age groups
of 21 to 30 and 0 to 1 years were the most and the least infected individuals. Moreover, Candida spp. were significantly more common
in females compared to males (P value < 0.001). It was demonstrated that the prevalence of C. albicans had significantly declined
from 2013-2014 to 2015. Furthermore, the prevalence of C. tropicalis was significantly higher in 2014 compared to 2013 and 2015.
Moreover, all the species had a colony count of > 103.
Conclusions: In this study, C. albicans was the most common species isolated from patients with vulvovaginitis and UTI, and signif-
icantly more common amongst females compared to males. The prevalence of candida spp. had significantly declined from 2013 to
2015. Moreover, the candida spp. counts were mostly higher than 103cfu/mL.
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1. Background
Candida spp. are members of a genus, including closely
related fungal species, such as Candida albicans (C. albi-
cans), C. tropicalis and C. parapsilosis, and in addition, dis-
tantly related organisms including C. glabrata and C. kru-
sei (1, 2). Candida spp. are among common causative
agents of nosocomial infections in the United States, Eu-
rope and other parts of the world (3). Candida albicans re-
mains the predominant species in related infections, al-
though recent studies suggest an increase in the propor-
tion of species other than C. albicans, such as C. glabrata,
C. tropicalis, C. parapsilosis and C. krusei (4, 5). Candida
spp. commonly colonize the gut, oral and vaginal cavity
in healthy individuals. However, they are also capable of
causing disease under circumstances that prosper their
overgrowth and damage of the host (6). The range of dis-
eases caused by the species varies from superficial and be-
nign infections of the mucosae, such as oropharyngeal or
vulvovaginal candidiasis, to severe life-threatening condi-
tions of disseminated or invasive candidiasis; especially in
immune-compromised patients (7-10). The most impor-
tant factors predisposing individuals to mucosal related
infections include Human Immunodeficiency Virus (HIV)
infection, diabetes, antibiotic consumption and use of im-
munosuppressive drugs and extremes of age (11-13). Vulvo-
vaginal candidiasis is common in certain conditions, even
in otherwise healthy females (14). Risk factors for UTIs in-
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clude female gender, age of 65 years or older, deficiency
of immune system, and urinary catheters (15). Although
candiduria is often associated with a benign outcome (16),
several large studies of hospitalized patients have demon-
strated decreased survival of patients with candiduria in
comparison with respective control populations (17, 18).
Candiduria leads to systemic infection or candidemia only
in 0 - 8% of the cases (19-21). Therefore, it remains unclear
if candiduria leads directly to mortality or alternatively
merely constitutes a surrogate marker.
2. Objectives
The aim of this study was the assessment of prevalence
of candiduria and vulvovaginitis candidiasis among pa-
tients attending a referral laboratory in Neyshabur during
2013 - 2015.
3. Methods
3.1. Patients and Collection of Fungal Species
This cross-sectional epidemiologic study was carried
out in Neyshabur and countryside rural areas between
2013 and 2015 to determine the prevalence of candiduria
in Neyshabur district. A total of 421 vulvovaginitis samples
were collected in this study. Patients of all ages, all ethnic-
ities and from both rural and urban areas were included.
Patients from other cities were excluded. Moreover, Can-
dida spp. from other infection sites other than UTI were ex-
cluded.
Samples were collected from patients complaining of
urinary tract pains, dysuria or discharge and pus secre-
tions.
3.2. Identification Procedures
Briefly, 10 µL of each un-centrifuged sample was cul-
tured on CHROM agar plates and incubated at 37°C for
24 to 48 hours, aerobically. Candida species were identi-
fied based on colony morphology on CHROM agar (CHROM
agar Candida®, France), germ tube production and micro-
morphology on corn meal agar including 1% Tween 80.
The materials and methods were tested for quality and
confirmation was achieved with the following approaches:
the micro tubes had been sterile, samplers had been cal-
ibrated, the CHROM agar medium was prepared from a
valid corporation, and the culture of samples was con-
ducted under sterile conditions and using 70% ethanol
for disinfection. Furthermore, a valid microscope was em-
ployed for morphology diagnosis.
Support for this study was obtained from the research
and technology deputy of ACECR, Mashhad Branch.
Several variables were assessed such as age, gender,
years and months and living in rural or urban places. These
criteria were considered in some previous published stud-
ies found in our literature search (22-24). However, some of
variables may not specifically or certainly be related to the
predisposition of candiduria.
3.3. Data Analysis
Data were analyzed with the SPSS software version 20
(IBM SPSS statistics for windows, version 20, Armonk, NY,
IBM Corp.), using the chi-square and one-way analysis of
variance (ANOVA) tests. P values < 0.05 were considered
statistically significant. T- and F-tests were employed when
needed (between two groups or amongst more, respec-
tively).
3.4. Ethical Approval
This work was supported by ACECR and ethical ap-
proval was provided by this center.
The patients provided consent for this study, and no an-
imal model was examined here.
4. Results
The mean age of the patients was 34.7± 16.3. From Ta-
ble 1 and Figure 1, it is obvious that C. albicans was the pre-
dominant species isolated. Moreover, age groups of 21 to
30 and 0 to 1 years were the most and the least infected in-
dividuals. Moreover, Candida spp. were significantly more
common in female than male patients (P value < 0.001, Ta-
ble 2).
It was demonstrated that the prevalence of C. albicans
was significantly declined from 2013-2014 to 2015. Fur-
thermore, the prevalence of C. tropicalis was significantly
higher in 2014 compared to 2013 and 2015 (Table 3 and Fig-
ure 2). Fifteen patients showed mixed infection of C. albi-
cans, E. coli and Enterobacter aerogenes isolates. Moreover,
all species had a colony count of > 103 (Table 4).
5. Discussion
To the best of our knowledge, this was the first study
assessing the prevalence of Candida spp. in patients from
Neyshabur, North-east of Iran. In the current study, the
mean age of patients was 34.7± 16.3. From Table 1 and Fig-
ure 1, it is obvious that C. albicans was the predominant
species isolated. This result is similar to a study from south
of Iran, in which C. albicans was predominant (48%) fol-
lowed by C. krusei (16.1%), C. glabrata (13.5%), C. kefyr (7.4%),
C. parapsilosis (4.8%), C. tropicalis (1.7%) and other species
(8.5%) (25). Moreover, age groups of 21 to 30 and 0 to 1 years
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Table 1. The Prevalence of Candida spp. Among Various Age Groups
C. albicans C. glabrata C. krusei C. spp. C. tropicalis Total P Value
Age
0 - 10 3 0 0 0 0 3 0.12
11 - 20 33 4 1 0 6 44 0.001
21 - 30 147 8 4 2 17 178 0.001
31 - 40 75 5 1 3 8 92 < 0.001
41 - 50 21 3 1 1 8 34 0.033
51 - 60 22 2 2 0 9 35 0.012
> 60 25 1 3 0 6 35 0.003
Total 326 (77.4) 23 (5.46) 12 (2.85) 6 (1.42) 54 (12.8) 421 (100)
Table 2. The Candida spp. Distribution Between Male and Female Patients
C. albicans C. glabrata C. krusei C. spp C. tropicalis Odds ratio Total P value
Female 321 23 12 6 51 4.46 413 < 0.0001
Male 5 0 0 0 3 1.33 8
Total 326 (77.4) 23 (5.46) 12 (2.85) 6 (1.42) 54 (12.8) 421 (100)
Table 3. The Incidence of Candida spp. According to Year
Year C. albicans C. glabrata C. krusei Candida spp. C. tropicalis Total
2013 138 4 2 2 4 150
2014 174 15 8 3 47 247
2015 14 4 2 1 3 24
P value < 0.001 0.011 0.276 0.412 0.0012 0.044
Total 326 (77.4) 23 (5.46) 12 (2.85) 6 (1.42) 54 (12.8) 421 (100)
Table 4. The Colony Counts of Candida spp. and the Prevalence in Each Count
Colony Count (CFU) < 1000 1001 - 5000 5001 - 10000 > 10000 Total (%)
C. albicans 59 39 79 149 326 (77.4)
C. glabrata 2 9 1 11 23 (5.46)
C. krusei 2 3 0 7 12 (2.85)
C.spp. 1 0 0 5 6 (1.42)
C. tropicalis 9 1 18 26 54 (12.8)
Total (%) 73 (17.3) 52 (12.4) 98 (23.3) 198 (47) 421 (100)
were the most and the least infected individuals. One of
reasons for more urethral infection among young adults
compared to children and other ages, may be because of
higher sexual activities. Moreover, Candida spp. exhib-
ited significantly higher rates amongst female than male
patients (P value < 0.001), indicating the greater vulner-
ability of females to candida UTI. In this study, C. albicans
was the most common species (77.4%) followed by C. trop-
icalis (12.8%), C. glabrata (5.46%), C. krusei (2.85%) and other
candida spp. (1.42%) remaining unspecified. In agreement
with our results, a study by Shokohi showed that C. albi-
cans was the predominant species (77.5%), followed by C.
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Figure 1. The Schematic Representation of Age Groups Infected With Candida spp.
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Figure 2. The Frequency of Candida spp. According to Year
glabrata (15%), C. tropicalis (5%) and C. krusei (2.5%) by Poly-
merase Chain Reaction-Restriction Fragment Length Poly-
morphism (PCR-RFLP) (26). In another study by Zarei Mah-
moudabadi, the prevalence of Candida spp. among 300
females was determined as 49%. On the other hand, re-
current and acute vaginal candidiasis was 48.3% and 51.7%,
respectively. In addition, C. albicans was the most preva-
lent species among the isolates followed by C. glabrata, C.
dubliniensis and other Candida species (27). Rad’s study
demonstrated that C. albicans was the most common (67%)
species amongst single and mixed infections and other
identified species included: C. glabrata (18.3%) followed by
C. tropicalis (6.8%), C. krusei (5.8%), C. parapsilosis (1.6%) and
C. guilliermondii (0.5%) (28). These studies revealed that
C. albicans is the most common candida in vulvovagini-
tis. In another study, it was confirmed that C. albicans and
C. glabrata were the predominant species isolated from
the specimens. However, the difference amongst previ-
ous studies and the present study includes epidemiologi-
cal differences, different years on which the study was con-
ducted, different sample sizes and sources of infections,
ages and gender of patients.
The mixed infection of C. albicans and C. glabrata was
demonstrated among 29 patients, while mixed infection of
C. albicans, Escherichia coli and Enterobacter aerogenes iso-
lates was observed among 15 patients. In a study by Mo-
hammadi, a mix of C. glabrata and C. albicans was the most
usual mixed infection from a total of 855 yeast strains iso-
lated from different clinical specimens (29).
It was demonstrated that the prevalence of C. albicans
has significantly declined from 2013-2014 to 2015. Fur-
thermore, the prevalence of C. tropicalis was significantly
higher in 2014 compared to 2013 and 2015. Moreover, all the
species had a colony count of > 103. The weak points of the
current study were lack of molecular method for the iden-
tification of species, narrow area of study, lack of antibi-
otic susceptibility test of species, and vagueness in the ed-
ucation level and economic status of patients. The strong
points include the relatively high number of isolates col-
lected from the study area for three years.
In this study, the most common mixed infection was
the combination of C. albicans and C. glabrata. Individu-
als, who were sexually active and those with urogenital sex
were more likely to have recurrent vulvovaginal and ure-
thral candidiasis.
5.1. Conclusion
In this study, C. albicans was the most common species
isolated from vulvovaginitis and urethral infection. The
prevalence of Candida spp. was significantly declined from
2013 to 2015. Moreover, the Candida spp. counts were
mostly higher than 103cfu/mL. The mixed infection of C. al-
bicans, C. glabrata, Escherichia coli and E. aerogenes was ob-
served among several patients.
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